← All trials
NCT05073029
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 10, 2019
- Primary completion
- Sep 10, 2019
- Completion date
- Nov 10, 2019
- First posted
- Oct 11, 2021
- Last posted
- Oct 11, 2021
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bogomolets National Medical UniversityLead sponsor
- Bogomolets National Medical UniversityReponsible party - principal investigator
- Taras Shevchenko National University of KyivCollaborator
- Taras Shevchenko National University of KyivStudy director
- Taras Shevchenko National University of KyivStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.